DIALysis With EXpanded Solute Removal

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 4800 participants.

Also called NCT06660277

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 4,800 participants (planned count) (from the registry)
Registry
  • NCT NCT06660277
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06660277. Randomized; no masking; primary purpose treatment. Start 2025-08-12 (actual); primary completion 2031-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DIALysis With EXpanded Solute Removal
Acronym
DIALEX
Condition
Chronic Kidney Disease Requiring Hemodialysis
Condition
End-Stage Kidney Disease (ESKD)
Condition
Chronic Kidney Disease Requiring Chronic Dialysis
Condition
Pragmatic Randomized Controlled Trial
Condition
Kidney Disease
Condition
Renal Insufficiency, Chronic
Condition
Kidney Failure, Chronic
Condition
Hemodialysis
Intervention (Device)
Super High-Flux Dialyzer
Intervention (Device)
High-Flux Dialyzer
Lead sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (class: other)
Collaborator
Schulich School of Medicine and Dentistry (class: not stated)
Collaborator
ICES (class: industry)
Collaborator
Nipro Canada Corporation (class: not stated)
Collaborator
London Health Sciences Centre (class: other)
Collaborator
Statistics Canada (class: not stated)

Record details

Record id
cardio:ct-nct06660277
Content hash
042f7dc4a1e284f89417b7462b6477f4795642918dd012a4c41c270f595685d4